Why Being There Actually Matters
Now, you might think any global healthcare giant could just ship its products to Brazil and call it a day. You would be wrong. To me, the real opportunity lies with the companies that have put proper boots on the ground. It’s one thing to export, it’s another entirely to build factories, run clinical trials, and understand the local market from the inside.
Take a look at the big players. Sanofi, the French pharmaceutical behemoth, isn't just sending over a few crates of pills. It runs multiple manufacturing sites across the country. GlaxoSmithKline has done something similar, using Brazil as a strategic hub to serve not just its domestic market but other parts of Latin America too. Then you have Novartis, the Swiss giant, which has woven itself into the fabric of the country’s healthcare system. These companies aren't just visitors, they are residents. This gives them a formidable advantage over fly by night competitors when it comes to navigating regulations and supply chains.
